Paris: US-based biopharmaceutical firm Gilead Sciences announced Monday that it entered into a definitive agreement to acquire cancer drug developer Arcellx for around $7.8 billion. The transaction included $115 per share in cash, and a contingent val…

Seoul: South Korea has declined a proposal from the United States to conduct a trilateral air drill with Japan this month. The suggested timing of the drill coincided with Tokyo’s annual commemoration of its territorial claim to a group of disputed is…

Paris: French President Emmanuel Macron on Monday emphasized the urgency for the European Union to advance its 20th sanctions package against Russia, indicating that discussions on the new punitive measures are expected “in the coming days.” Macron ma…